US › Healthcare

SIGA Technologies Inc (SIGA)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.05-1.61%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$41.0M

Revenue YoY

-49.5%

Net profit

$12.5M

Profit YoY

-64.9%

EPS

$0.17

Net margin

30.4%

Key statistics

Market cap

$217.7M

Forward P/E

2.8

P/B

1.31

Book value

$2.30

EPS (TTM)

$-0.04

52-week high

$8.36

52-week low

$2.83

50-day MA

$3.23

200-day MA

$4.92

Beta

0.89

Analyst view

with an average price target of $17.53.

Shareholding

Insiders

42.73%

Institutions

50.40%

Largest institutional holders

Fund	Stake
BlackRock Inc	4.86%
Dimensional Fund Advisors, Inc.	3.79%
AltraVue Capital, LLC	3.24%
Vanguard Capital Management, LLC	2.39%
Arrowstreet Capital Limited Partnership	2.12%
American Century Companies Inc	2.10%
Geode Capital Management, LLC	1.83%
AQR Capital Management LLC	1.70%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SIGA Technologies Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.